Artificial sweeteners — including aspartame (E951), sucralose (E955), saccharin (E954), acesulfame K (E950), and cyclamate (E952) — are synthetic compounds hundreds to thousands of times sweeter than sugar, used to sweeten food and drinks with minimal calories. Marketed as safe sugar alternatives and widely adopted in "diet," "light," and "sugar-free" products, this chemical class has become the subject of intense scientific scrutiny following evidence of gut microbiome disruption, paradoxical associations with weight gain and metabolic disease, and the reclassification of aspartame by IARC as a possible human carcinogen in 2023.
Where it's found
Diet and "zero sugar" soft drinks are the largest single source — aspartame and acesulfame K are near-universal in diet cola, diet lemonade, and sugar-free energy drinks. Sugar-free versions of sweets, chewing gum, yoghurt, and flavoured water. "Light" and "reduced sugar" versions of sauces, salad dressings, and condiments. Tabletop sweetener products (saccharin, aspartame, sucralose). Protein powders, sports supplements, and meal replacement products. Sugar-free medicines and vitamin supplements. Low-calorie and "healthy" ready meals. Sucralose is notable for its stability at high temperatures, making it widespread in baked goods.
Routes of exposure
Dietary ingestion from food and beverages is the sole significant exposure route. Aspartame is broken down in the gut to aspartate, phenylalanine, and methanol — the methanol is absorbed and converted to formaldehyde. Sucralose is poorly absorbed and passes largely intact through the gut, but is actively taken up by gut bacteria. Saccharin and cyclamate are absorbed and excreted in urine with minimal metabolism. The gut microbiome is exposed to all non-absorbed sweeteners at higher effective concentrations than circulating body tissues.
Health concerns
IARC classified aspartame as a Group 2B possible human carcinogen in July 2023, based on limited evidence of hepatocellular carcinoma association in human studies and mechanistic evidence. JECFA concurrently concluded the acceptable daily intake remained appropriate for the general population, creating a nuanced regulatory picture. Multiple human intervention studies have found that non-caloric sweeteners (particularly saccharin and sucralose) alter gut microbiome composition and impair glycaemic control — challenging the assumption that calorie-free sweeteners are metabolically neutral. Population studies find positive associations between high artificial sweetener consumption and cardiovascular disease, metabolic syndrome, and weight gain — contradicting the expected effect of replacing sugar with no-calorie alternatives.
Evidence
Genuine scientific controversy exists between IARC's cancer classification (based on epidemiological and mechanistic evidence) and JECFA's safety conclusion for aspartame. Gut microbiome disruption evidence is consistent across human and animal studies. Epidemiological associations with metabolic disease are present but could reflect reverse causation (people who drink diet drinks may already have metabolic disease). The overall picture is of a chemical class that is meaningfully less safe than long assumed, but without the definitive human carcinogenicity evidence of Group 1 carcinogens.
Who's most at risk
People with phenylketonuria (PKU) must avoid aspartame entirely — phenylalanine release is directly toxic due to the metabolic disorder. Children consuming diet drinks and sugar-free products as a significant part of their diet have gut microbiome disruption risk during critical microbiome establishment periods. Pregnant women consuming artificial sweeteners have been found in some studies to have children with higher rates of obesity — though confounding is difficult to exclude.
Regulatory status
RegulationAll permitted artificial sweeteners in the EU require approval under Regulation (EC) 1333/2008. Aspartame remains approved in the EU and UK with an ADI of 40 mg/kg body weight/day. Products containing aspartame must carry the statement "contains a source of phenylalanine" for PKU sufferers. IARC 2B classification does not trigger regulatory restriction automatically — it indicates a hazard that authorities must evaluate against exposure levels. No changes to EU approval have been made following the 2023 IARC classification.
How to reduce your exposure
Reduce reliance on sweetened drinks of all kinds — water, plain sparkling water, and unsweetened tea and coffee avoid both sugar and sweetener concerns. When choosing between sugar and artificial sweeteners, consider the overall dietary context — neither is ideal as a routine daily habit. Whole fruit provides sweetness with fibre, micronutrients, and bioactive compounds absent from all sweetened products. Read ingredient labels on "healthy," "light," and "diet" products carefully — artificial sweeteners are pervasive in products marketed to health-conscious consumers.
The nutrition connection
The sweetener debate sits at the intersection of nutritional science and food chemistry that Nutriofia is built to navigate. The premise of artificial sweeteners — that a chemical can replicate the sensory experience of sugar without any metabolic consequence — appears increasingly questionable in light of gut microbiome, metabolic signalling, and emerging carcinogenicity evidence. The nutritional case for replacing whole food sweetness (fruit, small amounts of honey or maple syrup) with synthetic intense sweeteners becomes harder to make when the claimed benefit (calorie reduction) is not reliably delivered and the risk profile is not as clean as previously assumed.